Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1997-8-18
|
pubmed:abstractText |
The binding of [3H]raclopride to particulate membrane and frozen sections (with quantitative autoradiography) from the caudate-putamen, obtained at autopsy from schizophrenic and non-schizophrenic subjects, was measured. The affinity of [3H]raclopride to particulate membrane was significantly decreased in the schizophrenic compared to non-schizophrenic subjects. The density of [3H]raclopride binding to tissue from subjects with schizophrenia was increased, unchanged or decreased depending on the methodology used. Finally, there was an age-dependent decrease in [3H]raclopride binding in the frozen sections from the caudate-putamen of the non-schizophrenic subjects. This age-dependent decrease was not apparent using particulate membrane from schizophrenic or non-schizophrenic subjects or tissue sections from the schizophrenic subjects. We conclude that the binding of [3H]raclopride is dependent on methodology and therefore data from in vitro and in vivo studies using this drug should be interpreted with caution.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0028-3908
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
36
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
779-86
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9225305-Adult,
pubmed-meshheading:9225305-Aged,
pubmed-meshheading:9225305-Autoradiography,
pubmed-meshheading:9225305-Brain,
pubmed-meshheading:9225305-Caudate Nucleus,
pubmed-meshheading:9225305-Cell Membrane,
pubmed-meshheading:9225305-Dopamine Antagonists,
pubmed-meshheading:9225305-Female,
pubmed-meshheading:9225305-Humans,
pubmed-meshheading:9225305-Male,
pubmed-meshheading:9225305-Middle Aged,
pubmed-meshheading:9225305-Protein Binding,
pubmed-meshheading:9225305-Putamen,
pubmed-meshheading:9225305-Raclopride,
pubmed-meshheading:9225305-Receptors, Dopamine D2,
pubmed-meshheading:9225305-Salicylamides,
pubmed-meshheading:9225305-Schizophrenia
|
pubmed:year |
1997
|
pubmed:articleTitle |
[3H]raclopride binding to brain tissue from subjects with schizophrenia: methodological aspects.
|
pubmed:affiliation |
Rebecca L. Cooper Research Laboratories, Mental Health Research Institute of Victoria, Parkville, Australia. bdean@papyrus.mhri.edu.au
|
pubmed:publicationType |
Journal Article,
In Vitro,
Research Support, Non-U.S. Gov't
|